Supported current and legacy diagnostic and therapeutic electrophysiology catheter lines and their associated supply chains. Projects include:•Evaluated, prototyped, and implemented new components to improve device performance, cost, and supply chains•Developed and revised processes for materials such as Vectra LCP, Nitinol, Platinum-Palladium alloy, UHMWPE, PTFE, PU, etc.•Compounded melt-processable PTFE alternatives to reduce component costs and improve business continuity across several J&J franchises•Collaborated with suppliers to validate, scale up, optimize, and troubleshoot both new and existing manufacturing processes•Implemented design, process, and test method improvements across internal and external manufacturing•Served as the technical lead responsible for overseeing the management of change at external suppliers•Collaborated with other J&J Operating Companies to optimize both franchise and OpCo processes and procedures

Optimized and maintained needle forming, heat treatment, electropolishing, coating, and laser drilling processes yielding 947MM surgical needles/yr. Projects included:•Validation of a new automated production line and supporting equipment to achieve a 16% production capacity increase and 90k/yr savings•Redesigned process aids to reduce controllable machine downtime by 47% and machine utilization by 4.7% •Modification of needle forming processes to increase yield by 2.5%, mitigate uncontrollable machine downtime, and eliminate tooling costs of 30k/yr•Harmonization of franchise test methods through the development and global implementation of automated QA inspection systems and test methods•Resolved organization-wide equipment issues through the modification of machine design•Qualification of internal and external suppliers of Tungsten-Rhenium, 420SS, and proprietary Ethalloy stainless steel alloys•Execution of business critical tier 1 and tier 2 supplier qualification activities to prevent production shutdowns•Collaboration with R&D, Marketing, and Product Management to translate competitive performance testing and VoC results into design and process improvements•Support for new product development activities•Serving as the Cornelia site co–op lead and mentoring 11 new co–ops

Optimized and maintained the extrusion and processing of non-absorbable suture fiber processes yielding 53MM units/yr. Projects included:•Modification of monofilament fiber extrusion parameters to reduce scrap caused by visual and physical property failures•Revision of automated topographical fiber inspection system parameters to reduce quality escape rates•Collaboration with finishing sites to validate production of nylon suture fiber from the Ethicon Athens site•Validation of a new sterilization facility for fine–size nylon sutures•Scrap rate reduction through the implementation of a new dying process for nylon sutures•Product transfer of a hernia mesh to another internal site

Provided direct engineering support to operations in the extrusion and processing of 827MM units/yr. Projects included:•Execution of cost-saving design change activities to processes aids•Validation activities on various pieces of equipment to improve production capacity and workflow•Design and implementation of new processes using LEAN methodologies•Design, prototyping, and implementation of new manufacturing and machine guarding equipment •Identification of process bottlenecks via value stream mapping•Support for the J&J One Georgia Campus initiative to unify both Georgia campuses in the spirit of the J&J Credo

•Supported the development of graphene-based sensors to measure electrical flux in cardiomyocytes•Created a test bed for prototype sensors by establishing in-house cell cultures

Conducted nanomaterial-related research, which included:Inorganic Biomaterials• Objective: Conduct comprehensive to develop novel Cerium Oxide (CeO2) nanoparticle-based therapeutic systems• Led a group of 16 Creative Inquiry students in growing cell cultures and running various assays• Characterized CeO2 nanoparticles through the use of dynamic light scattering (DLS) and transmission electron microscopy (TEM)• Determined the effects of CeO2 on Catalase, Lysozyme, and SOD enzymes through circular dichroism (CD)• Encapsulated CeO2 nanoparticles in PLGA to deliver their therapeutic properties• Published findings in Biomedical Sciences Instrumentation Volume 55(1), January 2019: pgs 14-19 “PLGA Encapsulation of Nanoceria and Superoxide Dismutase (SOD) Yields a Deliverable, Antioxidative Therapy”•Project findings presented at several conferences, including Biomedical Engineering Society annual meeting 2018, Society for Biomaterials annual meeting 2019, Southern Biomedical Engineering Conference 2019, Clemson University Biomaterials Day 2018, Clemson Creative Inquiry Summer Showcase 2018OLED for Biomedical Applications• Objective: Develop and synthesize CdSe-based quantum dots and explore their biomedical uses• Created and utilized quantum dots to enhance the delivery process of photo-sensitive drugs• Presented findings at the Clemson Focus on Creative Inquiry poster forum, which received the best poster award

•Planned and hosted two weekly review sessions for students in General Chemistry I•Collaborated with professors to create plans of action based on students’ needs •Held weekly meetings with other leaders as well as graduate assistants in order to continuously improve attendance, engagement, and quality of teaching in sessions

•Characterized materials and developed manufacturing processes for synthetic polyisoprene Foley catheters •Supported design transfer, NPI, and production scale up activities for latex urinary catheters & critical care devices•Designed dipping forms and revised manufacturing procedures to produce new variant products•Executed design verification and validation activities to qualify a new external manufacturer of silicon catheters•Modified polyisoprene compounding process to remove an accelerant classified under California Proposition 65